Real-time precision dosing for critical care

The right dose,for this patient,right now.

Titrix measures the antibiotic in a patient's blood at the bedside in about 20 minutes, then uses predictive AI to build that patient's own pharmacokinetic profile and recommend the next dose — keeping them inside the therapeutic window.

01 — The problem

The ICU patient is a moving target.

Antibiotic doses follow standard nomograms, designed around average patients. ICU patients don't fit them: critical illness rewrites how a body handles a drug, and clearance can double, or collapse, within a day. For narrow-therapeutic-index antibiotics the same dose can be too little for one patient and toxic for the next.

Clinicians are left adjusting doses with limited information. Where drug levels are measured at all, samples travel to a central lab and results come back 6 to 20 hours later — often after the next dose has already been given.

50–55%

of narrow-therapeutic-index antibiotic treatments in the ICU fail to keep the patient inside the therapeutic window.

Neely et al., Antimicrob Agents Chemother 2018

6–20 h

for a hospital lab to return a drug-concentration result — usually after the next dose is already in.

Martin-Loeches, Expert Rev Anti Infect Ther 2022

1.5M

ICU patients a year in the EU and USA whose altered physiology no standard nomogram fits.

Roberts, Crit Care Med 2009

Under-dosing lets infections persist and drives antimicrobial resistance. Over-dosing harms kidneys and nerves. Both are invisible without a measurement.

02 — Titrix

Same patient.
Two strategies.

A simulated septic patient with augmented, drifting renal clearance — one of the most common reasons ICU antibiotic levels fall short. Fixed dosing swings above and below the target, and a lab level takes 6 to 20 hours to come back. Titrix reads the level at the bedside in about 20 minutes, learns this patient, and corrects.

Time in therapeutic range

35%
Standard dosing
100%
With Titrix
Toxicity riskTherapeutic windowTreatment failure · resistancelab result back after ~6 h0h12h24h36h48h
  • ▲ Standard: fixed bolus every 8 h
  • □ Lab level: result in 6–20 h, after the next dose is already in
  • ○ Titrix: bedside level every 4 h, result in ~20 min → re-titrated dose

Illustrative simulation — not clinical data.

03 — How it works

A closed loop around every dose.

MeasureModelRecommendAdapt
Titrixmeasure
  1. 01At the bedside

    Measure

    A drop of blood goes into a single-use lab-on-chip cartridge. About 20 minutes later Titrix has the antibiotic concentration, next to the bed — not from a central lab 6 to 20 hours later.

  2. 02Patient-specific AI

    Model

    Predictive AI combines each measurement with the patient's clinical data — renal function, body weight, fluid balance, organ support — into a patient-specific pharmacokinetic profile: a digital twin of how this body handles the drug.

  3. 03Clinician in control

    Recommend

    Titrix proposes the next dose and its timing, alongside the expected exposure. The recommendation supports the clinician's decision; it never replaces it.

  4. 04The loop closes

    Adapt

    Every new measurement refines the profile as organ function shifts, keeping exposure inside the therapeutic window for the whole course of therapy.

01

Bedside, not backlog

Results in about 20 minutes, while they can still change the next dose.

02

Patient-specific

Dosing driven by this patient's measured exposure, not a population average.

03

Decision support

Titrix recommends. Clinicians decide. Every suggestion is explainable.

04

Hardware + software

The first integrated measure-and-dose workflow built specifically for the ICU.

04 — Company

πρᾶγμα

/ˈpraɡ.ma/ from Greek: a deed; the thing done.

PRAGMA Diagnostics is an early-stage MedTech startup from Milan, turning complex technology into lifesaving tools for critical care — and building a business that puts ethics and people first.

We are engineers, computer scientists, clinical-data and business specialists from Politecnico di Milano, Humanitas University and Bocconi. Our first product, Titrix, is the first integrated hardware-and-software solution for ICU antibiotic dosing, shaped by interviews with intensive-care doctors — so that every patient receives exposure matched to their own physiology, and the antibiotics we still have keep working.

Let's close
the loop together.

Clinical partners

ICUs, intensivists and clinical pharmacists who want to shape, validate and pilot Titrix.

Become a pilot site→

Investors

We are taking Titrix from validated concept to MVP and first pilot. Let's talk about what comes next.

Request our deck→

Talent

Engineers, scientists and clinicians who want to turn complex technology into lifesaving tools.

Get in touch→